oncology
Breast Cancer

Why we need to talk more about chemotherapy toxicity and dose adjustment

Patients receiving adjuvant chemotherapy will need more dose adjustments to avoid toxicity than those recommended in protocols based on unrealistic clinical trials, a review shows. In real world practice many chemotherapy patients are having higher rates of treatment-related toxicity than the carefully selected and monitored participants in clinical trials, according to a review of evidence ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic